These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 456389)

  • 1. Transient hyperkinesia after a single intravenous perfusion of diphenylhydantoin. Report of a case associated with nontoxic plasma levels of diphenylhydantoin.
    Mauguière F; Dalery J; de Villard R; Courjon J
    Eur Neurol; 1979; 18(2):116-23. PubMed ID: 456389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotransmitter metabolites in medicated epileptic patients.
    Markianos M; Kalfakis N
    Funct Neurol; 1991; 6(4):367-70. PubMed ID: 1725777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin-induced hyperkinesia.
    Lühdorf K; Lund M
    Epilepsia; 1977 Sep; 18(3):409-15. PubMed ID: 891495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate and monoamine metabolism in epilepsy.
    Reynolds EH; Chadwick D; Jenner P; Chanarin I
    J Neurol Sci; 1975 Dec; 26(4):605-15. PubMed ID: 1206436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between estimated premorbid adjustment and CSF homovanillic acid and 5-hydroxyindoleacetic acid levels.
    Leckman JF; Bowers MB; Sturges JS
    Am J Psychiatry; 1981 Apr; 138(4):472-7. PubMed ID: 6163366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Central metabolism of dopamine and serotonin. IV. Preliminary determinations of cerebrospinal fluid HVA and 5-HIAA in epileptic syndromes].
    Mandarini A; Buscaino GA; Rossi V; Orefice G; Carrieri P; Campanella G
    Acta Neurol (Napoli); 1976; 31(5):628-31. PubMed ID: 1015386
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum diphenylhydantoin in epileptic patients (preliminary report)].
    Radzikowska B; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1977; 11(5):551-4. PubMed ID: 593505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of anticonvulsant level determination in the treatment of epilepsies].
    Loiseau P; Brachet-Liermain A; Legroux M; Jogeix M
    Nouv Presse Med; 1977 Mar; 6(10):813-7. PubMed ID: 322087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiological observations on plasma levels of diphenylhydantoin in 130 patients on prolonged treatment (author's tranls)].
    Frigo GM; Perucca E; Teggia-Droghi M; Gatti G; Visintini D; Calzetti S; Poloni M
    Riv Patol Nerv Ment; 1976; 97(5):305-14. PubMed ID: 1032214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (HIAA) in the CSF after administration of probenecid in Huntington's chorea. Effect of lithium carbonate].
    Livrea P; Di Reda L; Ragno G; Germinario L; Papagno G
    Riv Neurobiol; 1977; 23(3):149-59. PubMed ID: 154166
    [No Abstract]   [Full Text] [Related]  

  • 11. Individual differences in basal cisternal cerebrospinal fluid 5-HIAA and HVA in monkeys. The effects of gender, age, physical characteristics, and matrilineal influences.
    Raleigh MJ; Brammer GL; McGuire MT; Pollack DB; Yuwiler A
    Neuropsychopharmacology; 1992 Dec; 7(4):295-304. PubMed ID: 1282317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Paroxysmal dyskinesia during treatment with diphenylhydantoin].
    Dravet C; Dalla Bernardina B; Mesdjian E; Galland MC; Roger J
    Rev Neurol (Paris); 1980; 136(1):1-14. PubMed ID: 7394437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma level studies on different brands of sodium diphenylhydantoin (DPH) and primidone.
    Borst SI; Lockwood CH
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):309-14. PubMed ID: 1242131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nil nocere. Unusual hyperkinetic syndromes following diphenylhydantoin administration].
    Diehl LW
    Munch Med Wochenschr; 1969 Aug; 111(34):1679-81. PubMed ID: 5820099
    [No Abstract]   [Full Text] [Related]  

  • 15. Homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular CSF of comatose patients with obstructive hydrocephalus.
    Inagawa T; Ishikawa S; Uozumi T
    J Neurosurg; 1980 May; 52(5):635-41. PubMed ID: 6154788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of diphenylhydantoin in 41 epileptics institutionalized since childhood.
    Herberg KP
    South Med J; 1977 Jan; 70(1):19-24. PubMed ID: 190707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overnight sleep EEG and cerebrospinal fluid monoamines in seizures induced by movement.
    Fukuyama Y; Ochiai Y; Hayakawa T; Miyagawa F
    Neuropadiatrie; 1979 May; 10(2):138-49. PubMed ID: 226908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of HVA and 5-HIAA in epileptic syndromes in basal conditions and after treatment with probenecid].
    Carrieri P; Orefice G; Mandarini A; Rossi V; Campanella G
    Acta Neurol Quad (Napoli); 1979; 39():42-7. PubMed ID: 95499
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
    Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
    Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.